Didanosine-associated toxicity: a predictable complication of therapy with tenofovir and didanosine?

J Acquir Immune Defic Syndr. 2004 Apr 1;35(4):427-8. doi: 10.1097/00126334-200404010-00013.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adenine / administration & dosage
  • Adenine / adverse effects
  • Adenine / analogs & derivatives*
  • Adult
  • Anti-HIV Agents / administration & dosage
  • Anti-HIV Agents / adverse effects*
  • Creatinine / blood
  • Didanosine / administration & dosage
  • Didanosine / adverse effects*
  • Drug Interactions
  • Drug Therapy, Combination
  • Female
  • HIV Infections / drug therapy*
  • Humans
  • Kidney Diseases / blood
  • Kidney Diseases / chemically induced
  • Male
  • Middle Aged
  • Organophosphonates / administration & dosage
  • Organophosphonates / adverse effects*
  • Tenofovir

Substances

  • Anti-HIV Agents
  • Organophosphonates
  • Tenofovir
  • Creatinine
  • Adenine
  • Didanosine